TREM2 and Alzheimer disease: These data suggest that the recovery of the glycolytic switch by the activation of PPARγ‐p38MAPK/PFKFB3 signaling is sufficient to rescue TREM2‐dependent microglial functions such as phagocytosis of Aβ in AD.